To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF652TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
353 supporting clones for gene ZNF652 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DN998934 bone marrow .a 1 to 699 1 to 699   tiling clone,   699/699
(100 %)
5 diff
(99.3 %id)
NM_001145365.1   .a 8 to 11499 1 to 11492 exact RefSeq,   11492/11492
(100 %)
0 diff
(100 %id)
AK292667 thymus .a 18 to 2797 1 to 2780 R28C V50E I320T S579G     2780/2780
(100 %)
5 diff
(99.9 %id)
DB136029 thymus .a 19 to 568 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
CB050643 Prostate .a 124 to 753 6 to 635   fully sequenced,   630/635
(99 %)
7 diff
(98.9 %id)
DA652302   .a 156 to 701 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
CR933680 testis .a 157 to 4703 1 to 4546 exact tiling clone, AAA   4546/4546
(100 %)
4 diff
(100.0 %id)
CB050642 Prostate .a 723 to 1180 569 to 112   fully sequenced,   458/569
(80 %)
0 diff
(100 %id)
AB023141 brain .b 1 to 5429 1 to 5428 exact tiling clone, available from KIAA,   5428/5428
(100 %)
2 diff
(100.0 %id)
BC152440 Clones donated by Kazusa DNA Research Inst. .b 1 to 5429 1 to 5428 exact AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 5428/5428
(100 %)
2 diff
(100.0 %id)
NM_014897.2   .b 1 to 11347 1 to 11347 exact RefSeq,   11347/11347
(100 %)
0 diff
(100 %id)
DR005412 Prostate .b 72 to 763 7 to 697       691/697
(99 %)
2 diff
(99.8 %id)
DA292630 hippocampus .b 110 to 679 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB035230 testis .b 131 to 692 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BC139779 PCR rescued clones .b 146 to 2211 1 to 2066 exact     2066/2066
(100 %)
0 diff
(100 %id)
AI989483 pooled germ cell tumors .b 293 to 857 573 to 9       565/573
(98 %)
0 diff
(100 %id)
CR976748 T-Lymphocytes .b 442 to 1205 1 to 770       770/770
(100 %)
10 diff
(98.8 %id)
BX644173   .b 469 to 1021 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BG987942 head_neck .b 560 to 788 45 to 272       228/277
(82 %)
7 diff
(97.5 %id)
W27160 eye, retina .b 624 to 1063 444 to 3       442/481
(91 %)
0 diff
(100 %id)
FN126911 breast carcinoma .b 755 to 836 1 to 82       82/82
(100 %)
0 diff
(100 %id)
M85719   .b 854 to 1202 1 to 349       349/349
(100 %)
3 diff
(99.2 %id)
BE814955 breast_normal .b 883 to 1003 1 to 121       121/135
(89 %)
11 diff
(91.9 %id)
BX499587 Liver .b 984 to 1654 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
BF740290 bocio_tumor .b 1085 to 1641 16 to 572       557/627
(88 %)
17 diff
(97.3 %id)
BF740289 bocio_tumor .b 1097 to 1660 1 to 566       566/566
(100 %)
7 diff
(98.8 %id)
BG998324 head_neck .b 1142 to 1456 22 to 334       313/334
(93 %)
11 diff
(96.8 %id)
BF932902 nervous_tumor .b 1232 to 1456 115 to 341       227/341
(66 %)
8 diff
(97.7 %id)
BF933374 nervous_tumor .b 1232 to 1456 115 to 341       227/341
(66 %)
8 diff
(97.7 %id)
BF741538 bocio_tumor .b 1250 to 1679 459 to 31     Submitted on the opposite strand 429/459
(93 %)
13 diff
(97.2 %id)
BF760315 colon .b 1456 to 1835 382 to 3     Submitted on the opposite strand 380/382
(99 %)
1 diff
(99.8 %id)
BI040132 nervous_tumor .b 1518 to 1916 407 to 9       399/407
(98 %)
1 diff
(99.8 %id)
BF911969 uterus_tumor .b 1571 to 1898 331 to 4     Submitted on the opposite strand 328/331
(99 %)
0 diff
(100 %id)
BF759998 colon .b 1598 to 1835 236 to 1     Submitted on the opposite strand 236/236
(100 %)
4 diff
(98.4 %id)
BE083615 breast .b 1628 to 1859 234 to 1     Submitted on the opposite strand 234/246
(95 %)
0 diff
(100 %id)
BI018211 marrow .b 1636 to 1839 207 to 4       204/207
(98 %)
0 diff
(100 %id)
BQ306384 breast .b 1952 to 2445 1 to 493       493/493
(100 %)
6 diff
(98.8 %id)
BQ305753 breast .b 1953 to 2445 1 to 492       492/492
(100 %)
7 diff
(98.6 %id)
BQ306388 breast .b 1953 to 2445 1 to 493       493/493
(100 %)
6 diff
(98.8 %id)
BQ306641 breast .b 1953 to 2445 1 to 492       492/492
(100 %)
7 diff
(98.6 %id)
BQ305750 breast .b 1956 to 2452 4 to 499       496/506
(98 %)
4 diff
(99.3 %id)
BQ306382 breast .b 1956 to 2445 1 to 489       489/489
(100 %)
6 diff
(98.8 %id)
BQ306385 breast .b 1959 to 2445 489 to 1       489/496
(98 %)
5 diff
(99.0 %id)
BQ305749 breast .b 1969 to 2445 477 to 1       477/477
(100 %)
0 diff
(100 %id)
BQ306414 breast .b 1969 to 2452 519 to 10       510/519
(98 %)
0 diff
(100 %id)
BQ307704 breast .b 1969 to 2445 1 to 476       476/476
(100 %)
2 diff
(99.6 %id)
BF899700 marrow .b 2002 to 2483 17 to 496       480/496
(96 %)
6 diff
(98.8 %id)
BX118167 liver and spleen .b 2085 to 2792 1 to 708       708/708
(100 %)
0 diff
(100 %id)
AW373278 breast .b 2132 to 2489 1 to 358       358/358
(100 %)
0 diff
(100 %id)
AW581481 pnet .b 2132 to 2489 1 to 358       358/358
(100 %)
0 diff
(100 %id)
AW608636 pnet .b 2132 to 2489 1 to 358       358/358
(100 %)
0 diff
(100 %id)
DB365120   .b 2265 to 2836 569 to 1       569/570
(99 %)
14 diff
(97.6 %id)
AA706892 liver and spleen .b 2345 to 2839 495 to 1       495/495
(100 %)
0 diff
(100 %id)
AI631589 pooled germ cell tumors .b 2366 to 2836 470 to 1       470/470
(100 %)
3 diff
(99.4 %id)
BP247666 Kidney .b 2412 to 2993 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
W86821 liver and spleen .b 2464 to 2841 384 to 1       384/384
(100 %)
8 diff
(98.0 %id)
BX951343   .b 2628 to 3236 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BE830934 marrow .b 2684 to 3029 357 to 7       351/357
(98 %)
0 diff
(100 %id)
BF363309 nervous_normal .b 2820 to 3251 462 to 28       435/462
(94 %)
0 diff
(100 %id)
AA625263 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2871 to 3305 1 to 435       435/435
(100 %)
0 diff
(100 %id)
AA372356 colon .b 3138 to 3302 1 to 165       165/165
(100 %)
1 diff
(99.4 %id)
DA290386 hippocampus .b 3154 to 3733 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
EH345706   .b 3187 to 3264 1 to 77       77/77
(100 %)
1 diff
(98.8 %id)
AU252826 neuroblastoma .b 3366 to 4041 1 to 678       678/678
(100 %)
22 diff
(96.8 %id)
AI444649 Liver .b 3866 to 4588 729 to 7       723/729
(99 %)
0 diff
(100 %id)
AW795964 uterus .b 3869 to 4024 171 to 18       154/184
(83 %)
0 diff
(100 %id)
BP334302 salivary gland .b 3986 to 4532 1 to 547   tiling clone,   547/580
(94 %)
1 diff
(99.9 %id)
BX957111   .b 4591 to 4956 71 to 436   tiling clone,   366/436
(83 %)
6 diff
(98.7 %id)
AA907411 carcinoid, lung .b 4617 to 5047 1 to 429     Submitted on the opposite strand 429/429
(100 %)
5 diff
(98.9 %id)
CN361981 embryonic stem cells, cell lines H1, H7, andH9 .b 4804 to 5429 1 to 626   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 626/626
(100 %)
4 diff
(99.4 %id)
BE895308 melanotic melanoma, skin .b 4881 to 5424 1 to 544       544/544
(100 %)
3 diff
(99.5 %id)
AL707995 human skeletal muscle .b 4971 to 5539 1 to 570       570/570
(100 %)
5 diff
(99.2 %id)
AI015480   .b 5015 to 5396 382 to 1       382/382
(100 %)
4 diff
(99.0 %id)
EC545812 Prostate .b 5036 to 5141 1 to 106       106/109
(97 %)
1 diff
(99.1 %id)
BU536862 mixed (pool of 40 RNAs) .b 5037 to 5457 1 to 425       425/428
(99 %)
8 diff
(98.2 %id)
EC459121 Prostate .b 5039 to 5136 7 to 105       99/110
(90 %)
6 diff
(94.6 %id)
EC546948 Prostate .b 5039 to 5141 7 to 108       102/111
(91 %)
2 diff
(98.2 %id)
AU252827 neuroblastoma .b 5143 to 5447 309 to 5   tiling clone,   305/700
(43 %)
0 diff
(100 %id)
AA514909 Prostate .b 5152 to 5384 8 to 240       233/240
(97 %)
6 diff
(97.5 %id)
CD688641 normal nasopharynx .b 5153 to 5639 34 to 520       487/520
(93 %)
7 diff
(98.7 %id)
AA834718 ovary .b 5239 to 5364 1 to 126       126/127
(99 %)
3 diff
(97.7 %id)
AW131982 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 5264 to 5458 199 to 5       195/212
(91 %)
0 diff
(100 %id)
AL589278 human spinal cord .b 5314 to 5839 1 to 527   tiling clone,   527/527
(100 %)
2 diff
(99.7 %id)
AA766025 germinal center B cell .b 5607 to 5985 389 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 379/379
(100 %)
0 diff
(100 %id)
EH348702   .b 5729 to 5798 1 to 70       70/70
(100 %)
1 diff
(98.6 %id)
BI492404 cochlea, ear .b 6125 to 6785 661 to 1   tiling clone,   661/661
(100 %)
1 diff
(99.9 %id)
BX484659   .b 6140 to 6803 1 to 664       664/664
(100 %)
0 diff
(100 %id)
BQ021890 placenta .b 6384 to 6811 445 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 428/428
(100 %)
2 diff
(99.6 %id)
AI472808 pooled .b 6462 to 6812 351 to 1   tiling clone,   351/359
(97 %)
0 diff
(100 %id)
CV572797 cornea, eye .b 6558 to 7167 1 to 607   tiling clone,   607/607
(100 %)
3 diff
(99.6 %id)
BX648398 human small intestine .b 6868 to 11345 4523 to 52   tiling clone, available from DKFZ, AAA Submitted on the opposite strand 4472/4540
(98 %)
0 diff
(100 %id)
BX641027 human salivary gland .b 6872 to 11338 4510 to 44   available from DKFZ, Submitted on the opposite strand 4467/4490
(99 %)
0 diff
(100 %id)
AL036450 brain .b 6875 to 7408 1 to 534       534/534
(100 %)
0 diff
(100 %id)
AA743564 germinal center B cell .b 6886 to 7167 1 to 282     Submitted on the opposite strand 282/282
(100 %)
0 diff
(100 %id)
AA744239 germinal center B cell .b 6886 to 7345 1 to 460     Submitted on the opposite strand 460/460
(100 %)
0 diff
(100 %id)
AA761111 germinal center B cell .b 6886 to 7330 1 to 445     Submitted on the opposite strand 445/445
(100 %)
0 diff
(100 %id)
AW444762   .b 6924 to 7446 538 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 523/523
(100 %)
1 diff
(99.9 %id)
DB229388 trachea .b 6966 to 7509 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BI059605 uterus_tumor .b 7012 to 7347 1 to 332       332/337
(98 %)
25 diff
(92.6 %id)
BU431584 lymph .b 7043 to 7551 8 to 516       509/516
(98 %)
6 diff
(98.9 %id)
TI_154153547   .b 7043 to 7655 80 to 691       612/617
(99 %)
8 diff
(98.8 %id)
DA721007   .b 7090 to 7651 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA407834 thalamus .b 7100 to 7654 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA326510 hippocampus .b 7269 to 7935 2 to 668   capped   667/667
(100 %)
3 diff
(99.6 %id)
DB290405 uterus .b 7289 to 7853 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
BF208438 bladder, carcinoma, cell line .b 7315 to 8034 1 to 711       711/806
(88 %)
23 diff
(97.2 %id)
CK001784 brain/CNS, Bulk tissue from Human Spinal cord .b 7349 to 8018 1 to 665       665/665
(100 %)
9 diff
(98.7 %id)
BG896210 cartilage .b 7382 to 7727 51 to 396       346/396
(87 %)
6 diff
(98.5 %id)
BX498844 Liver .b 7410 to 7717 1 to 309       309/309
(100 %)
2 diff
(99.4 %id)
BE694676 breast .b 7419 to 7908 1 to 486       486/486
(100 %)
9 diff
(98.2 %id)
DN917209   .b 7421 to 7603 1 to 183       183/183
(100 %)
3 diff
(98.4 %id)
CN411908 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 7451 to 8178 1 to 727       727/727
(100 %)
6 diff
(99.2 %id)
BU607811 Human Lung Epithelial cells, lung .b 7562 to 8320 774 to 17   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 758/758
(100 %)
1 diff
(99.9 %id)
N76443 liver and spleen .b 7590 to 7704 1 to 115       115/124
(92 %)
1 diff
(99.2 %id)
W90519 liver and spleen .b 7604 to 7996 1 to 398   fully sequenced,   398/398
(100 %)
5 diff
(98.8 %id)
DB227890 trachea .b 7612 to 8157 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BM987984 mixed .b 7619 to 8123 522 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 505/505
(100 %)
0 diff
(100 %id)
EH321499   .b 7626 to 7693 1 to 68       68/73
(93 %)
1 diff
(98.7 %id)
FN072213 breast carcinoma .b 7637 to 7694 1 to 59       59/60
(98 %)
3 diff
(95.0 %id)
DN917210   .b 7650 to 7863 214 to 1       214/214
(100 %)
0 diff
(100 %id)
EH343575   .b 7654 to 7733 1 to 80       80/80
(100 %)
1 diff
(98.8 %id)
AW967478   .b 7707 to 8319 609 to 1     Submitted on the opposite strand 609/611
(99 %)
13 diff
(97.9 %id)
DA317721 hippocampus .b 7707 to 8255 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BX110615 ovarian tumor, ovary .b 7745 to 8330 585 to 1   AAA Submitted on the opposite strand 585/585
(100 %)
4 diff
(99.4 %id)
AV727964 hypothalamus .b 7751 to 8344 646 to 53     Submitted on the opposite strand 594/647
(91 %)
0 diff
(100 %id)
BE885807 leiomyosarcoma, uterus .b 7751 to 8373 1 to 622       622/935
(66 %)
12 diff
(98.8 %id)
AA402013 ovarian tumor, ovary .b 7757 to 8150 1 to 394     Submitted on the opposite strand 394/394
(100 %)
1 diff
(99.8 %id)
AW044525 pooled .b 7757 to 8061 1 to 305     Submitted on the opposite strand 305/305
(100 %)
3 diff
(99.1 %id)
DA790648 brain .b 7765 to 8259 2 to 499   capped   498/498
(100 %)
5 diff
(99.0 %id)
BU178614 melanotic melanoma, skin .b 7766 to 8320 1 to 555   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 555/555
(100 %)
0 diff
(100 %id)
CA433410 mixed .b 7784 to 8320 553 to 17   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 537/537
(100 %)
0 diff
(100 %id)
CB146979 Liver .b 7791 to 8338 551 to 5     Submitted on the opposite strand 547/551
(99 %)
0 diff
(100 %id)
DA834089 placenta .b 7810 to 8547 2 to 739   capped   738/742
(99 %)
6 diff
(99.2 %id)
DA237093 brain .b 7813 to 8398 2 to 589   capped   588/588
(100 %)
4 diff
(99.4 %id)
DA490458 brain .b 7815 to 8389 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DB145955 thymus .b 7865 to 8425 2 to 562   capped   561/561
(100 %)
4 diff
(99.3 %id)
AI208548   .b 7869 to 8320 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AA402937 ovarian tumor, ovary .b 7871 to 8327 457 to 1     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
BX485691   .b 7883 to 8186 1 to 305     Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 305/305
(100 %)
6 diff
(98.1 %id)
DA241614 brain .b 7886 to 8460 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AA402408   .b 7890 to 8323 433 to 1     Submitted on the opposite strand 433/433
(100 %)
3 diff
(99.4 %id)
AL036451 brain .b 7893 to 8348 460 to 1       460/566
(81 %)
11 diff
(98.1 %id)
DA798243 brain .b 7925 to 8471 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA196288 amygdala .b 7930 to 8496 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AA699503 liver and spleen .b 7943 to 8320 390 to 13   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 378/378
(100 %)
1 diff
(99.8 %id)
W90520 liver and spleen .b 7966 to 8282 321 to 1   fully sequenced,   321/321
(100 %)
3 diff
(99.1 %id)
CD653529 Embryonic Stem cells .b 7983 to 8778 11 to 800       790/824
(95 %)
15 diff
(98.2 %id)
DA288249 corpus callosum .b 8030 to 8585 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA490197 brain .b 8030 to 8519 2 to 492   capped   491/491
(100 %)
2 diff
(99.6 %id)
DA408258 thalamus .b 8031 to 8575 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA791936 brain .b 8034 to 8582 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
AA251242 germinal center B cell .b 8036 to 8338 328 to 27     Submitted on the opposite strand 302/328
(92 %)
0 diff
(100 %id)
DA665792   .b 8048 to 8593 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA118736 cerebellum .b 8053 to 8598 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
BG824014 adenocarcinoma cell line, colon .b 8079 to 8574 1 to 512       512/966
(53 %)
20 diff
(98.0 %id)
DA435144 tongue, tumor tissue .b 8100 to 8683 2 to 585   tiling clone, capped   584/584
(100 %)
0 diff
(100 %id)
DA342441 substantia nigra .b 8104 to 8665 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AA700275 liver and spleen .b 8148 to 8318 171 to 1       171/171
(100 %)
2 diff
(98.9 %id)
DA520113 brain .b 8154 to 8718 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA521548 brain .b 8193 to 8758 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA498262 brain .b 8228 to 8805 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
DA493533 brain .b 8231 to 8812 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
CD653366 Embryonic Stem cells .b 8322 to 9142 7 to 823       817/880
(92 %)
16 diff
(98.2 %id)
DA395871 thalamus .b 8373 to 8968 2 to 597   capped   596/598
(99 %)
4 diff
(99.4 %id)
AA479379 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 8377 to 8649 1 to 273     Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 273/273
(100 %)
1 diff
(99.7 %id)
DB158421 thymus .b 8422 to 9015 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
AK093834 trachea .b 8423 to 11321 1 to 2899   tiling clone, available from FLJ,   2899/2899
(100 %)
0 diff
(100 %id)
DA994052 synovial membrane tissue from rheumatioidarthritis .b 8423 to 8978 2 to 557   capped   556/556
(100 %)
3 diff
(99.5 %id)
DB195748 trachea .b 8424 to 8982 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
CN272904 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 8444 to 9169 1 to 726       726/726
(100 %)
1 diff
(99.9 %id)
DA496854 brain .b 8445 to 9015 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA500992 brain .b 8466 to 9014 2 to 550   capped   549/549
(100 %)
3 diff
(99.5 %id)
DB200359 trachea .b 8481 to 9050 2 to 571   capped   570/571
(99 %)
4 diff
(99.3 %id)
BG165601 hypernephroma, cell line, Kidney .b 8585 to 9295 1 to 706       706/711
(99 %)
15 diff
(97.9 %id)
DA527199 brain .b 8609 to 9203 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA452732 tongue, tumor tissue .b 8672 to 9262 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
DA580897   .b 8674 to 9231 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
AA357457 Prostate .b 8739 to 9005 1 to 267       267/267
(100 %)
2 diff
(99.3 %id)
DA670854   .b 8758 to 9348 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DA347067 substantia nigra .b 8781 to 9275 2 to 500   capped   499/499
(100 %)
4 diff
(99.2 %id)
DA767265 tongue .b 8783 to 9340 2 to 560   capped   559/559
(100 %)
4 diff
(99.3 %id)
DA792247 brain .b 8795 to 9329 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
BF835662 head_neck .b 8798 to 9067 23 to 291       269/291
(92 %)
6 diff
(98.0 %id)
AA355371   .b 8852 to 9158 1 to 307       307/307
(100 %)
0 diff
(100 %id)
AW962132   .b 8853 to 9520 1 to 670       670/670
(100 %)
11 diff
(98.4 %id)
DA303431 hippocampus .b 8877 to 9469 2 to 595   capped   594/594
(100 %)
3 diff
(99.5 %id)
DA673142   .b 8900 to 9485 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
BU186304 embryonal carcinoma, cell line, testis .b 8911 to 9790 43 to 926       884/926
(95 %)
6 diff
(99.4 %id)
BE538353 cervix .b 8927 to 9612 1 to 695       695/697
(99 %)
26 diff
(96.3 %id)
CD300540 testis .b 8960 to 9777 7 to 829       823/842
(97 %)
6 diff
(99.3 %id)
BM453537 leiomyosarcoma, uterus .b 8979 to 9706 1 to 735       735/1014
(72 %)
11 diff
(99.0 %id)
N94141 liver and spleen .b 9127 to 9425 1 to 299   fully sequenced,   299/299
(100 %)
1 diff
(99.7 %id)
DA748064   .b 9146 to 9726 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
AA193086 muscle, skeletal muscle .b 9155 to 9481 1 to 326       326/326
(100 %)
1 diff
(99.7 %id)
BG258535 embryonal carcinoma, cell line, testis .b 9160 to 9895 1 to 730       730/981
(74 %)
26 diff
(97.4 %id)
CD686278 normal nasopharynx .b 9250 to 9773 34 to 557       524/557
(94 %)
6 diff
(99.0 %id)
BF528628 anaplastic oligodendroglioma with 1p/19qloss, brain .b 9262 to 10011 1 to 746       746/1098
(67 %)
25 diff
(97.8 %id)
DB207861 trachea .b 9267 to 9723 2 to 457   capped   456/456
(100 %)
1 diff
(99.8 %id)
CX784097 human embryonic stem cells .b 9366 to 9972 1 to 607       607/607
(100 %)
0 diff
(100 %id)
CN430284 embryonic stem cells, DMSO-treated H9 cellline .b 9368 to 9901 1 to 534       534/534
(100 %)
5 diff
(99.1 %id)
DA606431   .b 9388 to 9944 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
N63784 liver and spleen .b 9395 to 9845 451 to 1   fully sequenced,   451/451
(100 %)
0 diff
(100 %id)
DA082320 cerebellum .b 9401 to 9983 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
AA300029 uterus .b 9406 to 9716 1 to 311       311/311
(100 %)
0 diff
(100 %id)
AW954152   .b 9407 to 10117 1 to 712       712/712
(100 %)
2 diff
(99.8 %id)
AA336465 endometrium .b 9420 to 9779 1 to 362       362/362
(100 %)
3 diff
(99.2 %id)
AA278835 germinal center B cell .b 9450 to 9748 1 to 299       299/299
(100 %)
0 diff
(100 %id)
DB166253 thyroid gland .b 9488 to 10200 2 to 715   capped   714/714
(100 %)
10 diff
(98.6 %id)
DA142457 alzheimer cortex .b 9515 to 10050 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
DT218430 brain .b 9518 to 10189 1 to 672       672/672
(100 %)
2 diff
(99.8 %id)
AA479284 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 9535 to 9988 483 to 31   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 453/453
(100 %)
4 diff
(99.2 %id)
FN124626 breast carcinoma .b 9542 to 9632 92 to 2     Submitted on the opposite strand 91/95
(95 %)
0 diff
(100 %id)
CD697470 normal nasopharynx .b 9557 to 10114 22 to 579       558/579
(96 %)
6 diff
(99.0 %id)
BQ720114 sympathetic trunk .b 9586 to 10427 8 to 859       852/933
(91 %)
25 diff
(97.4 %id)
DA615319   .b 9588 to 10105 2 to 519   capped   518/518
(100 %)
5 diff
(99.1 %id)
TI_154185730   .b 9588 to 10296 116 to 822       707/977
(72 %)
10 diff
(99.0 %id)
BU838341 dorsal root ganglia .b 9596 to 10515 1 to 919       919/920
(99 %)
11 diff
(98.9 %id)
DA362264 subthalamic nucleus .b 9618 to 10161 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
DA362265 subthalamic nucleus .b 9618 to 10174 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
BF884294 lung_tumor .b 9675 to 10133 467 to 10     Submitted on the opposite strand 458/485
(94 %)
0 diff
(100 %id)
BC028045 Brain, glioblastoma with EGFR amplification .b 9703 to 11321 12 to 1630   available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1619/1619
(100 %)
0 diff
(100 %id)
BF342246 brain, glioblastoma with EGFR amplification .b 9703 to 10537 1 to 827   available from MGC,   827/873
(94 %)
39 diff
(95.6 %id)
CV575634 cornea, eye .b 9743 to 10345 1 to 603       603/603
(100 %)
0 diff
(100 %id)
CB129621 Liver .b 9848 to 10283 1 to 436       436/436
(100 %)
0 diff
(100 %id)
W23247 eye, retina .b 9872 to 10331 20 to 475       456/505
(90 %)
26 diff
(94.9 %id)
H79005 liver and spleen .b 9907 to 10319 1 to 421     Submitted on the opposite strand 421/427
(98 %)
17 diff
(96.1 %id)
FN145464 breast carcinoma .b 9912 to 9996 1 to 82       82/83
(98 %)
7 diff
(91.6 %id)
CN371384 embryonic stem cells, DMSO-treated H9 cellline .b 9942 to 10702 1 to 762       762/763
(99 %)
6 diff
(99.3 %id)
AA319755 adrenal gland .b 10072 to 10376 1 to 308       308/308
(100 %)
6 diff
(98.1 %id)
BF890874 marrow .b 10097 to 10588 501 to 8     Submitted on the opposite strand 494/533
(92 %)
0 diff
(100 %id)
BP421356 small intestine .b 10122 to 10577 1 to 456     Submitted on the opposite strand 456/456
(100 %)
0 diff
(100 %id)
CN371383 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 10197 to 10704 1 to 508       508/508
(100 %)
0 diff
(100 %id)
H78517 liver and spleen .b 10199 to 10585 389 to 1     Submitted on the opposite strand 389/399
(97 %)
3 diff
(99.3 %id)
CF141995 CNCAP(3)T-225 cell line, Prostate .b 10243 to 10480 8 to 245       238/245
(97 %)
6 diff
(97.6 %id)
TI_154172854   .b 10243 to 10843 81 to 681       601/601
(100 %)
5 diff
(99.2 %id)
BG741588 skin .b 10261 to 11092 1 to 833       833/833
(100 %)
2 diff
(99.8 %id)
AW452963   .b 10285 to 10563 299 to 21       279/301
(92 %)
0 diff
(100 %id)
BF082046 breast_normal .b 10343 to 10819 1 to 479       479/479
(100 %)
13 diff
(97.3 %id)
BQ669401 epidermoid carcinoma, cell line, salivary gland .b 10346 to 11181 1 to 857       857/954
(89 %)
42 diff
(95.6 %id)
AA361637   .b 10362 to 10669 1 to 309       309/309
(100 %)
1 diff
(99.7 %id)
AW953688   .b 10363 to 10991 1 to 630       630/633
(99 %)
26 diff
(95.9 %id)
TI_154117590   .b 10388 to 11340 1035 to 86   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 950/950
(100 %)
42 diff
(95.6 %id)
AI908444 breast .b 10399 to 10850 1 to 453       453/453
(100 %)
5 diff
(98.9 %id)
BE697466 colon .b 10415 to 10784 369 to 2       368/369
(99 %)
0 diff
(100 %id)
BE697467 colon .b 10415 to 10799 390 to 3       388/390
(99 %)
0 diff
(100 %id)
BE812800 amnion_normal .b 10415 to 10821 18 to 423       406/423
(95 %)
6 diff
(98.6 %id)
BE935457 marrow .b 10415 to 10592 1 to 179       179/186
(96 %)
6 diff
(96.8 %id)
BQ321220 colon .b 10464 to 10821 10 to 367       358/367
(97 %)
6 diff
(98.4 %id)
AW802043 uterus .b 10488 to 10738 253 to 3       251/253
(99 %)
0 diff
(100 %id)
FN088057 breast carcinoma .b 10495 to 10585 1 to 85       85/86
(98 %)
6 diff
(93.1 %id)
TI_159714882   .b 10518 to 11321 877 to 77   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 801/987
(81 %)
12 diff
(98.8 %id)
BQ321218 colon .b 10527 to 10821 54 to 354       301/354
(85 %)
24 diff
(93.3 %id)
BQ321219 colon .b 10529 to 10821 55 to 352       298/352
(84 %)
6 diff
(98.3 %id)
FN048447 breast carcinoma .b 10579 to 10640 62 to 1     Submitted on the opposite strand 62/63
(98 %)
0 diff
(100 %id)
CB322024 Human Lung Epithelial cells, lung .b 10580 to 11321 760 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 742/742
(100 %)
4 diff
(99.5 %id)
AA495759 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 10642 to 11036 1 to 392       392/392
(100 %)
3 diff
(99.3 %id)
TI_154128529   .b 10644 to 11321 797 to 119   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 679/679
(100 %)
4 diff
(99.5 %id)
R22889 placenta .b 10649 to 10897 1 to 264       264/300
(88 %)
11 diff
(96.4 %id)
BU607977 Human Lung Epithelial cells, lung .b 10664 to 11321 673 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 655/655
(100 %)
3 diff
(99.6 %id)
CA417602 Chondrosarcoma Cell line .b 10664 to 11346 694 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 678/678
(100 %)
2 diff
(99.8 %id)
AL596815 human spinal cord .b 10666 to 11319 657 to 4     Submitted on the opposite strand 654/657
(99 %)
0 diff
(100 %id)
AI985209 Kidney .b 10666 to 10986 65 to 385     Submitted on the opposite strand 321/385
(83 %)
6 diff
(98.5 %id)
N95749 multiple sclerosis lesions .b 10672 to 11095 1 to 429       429/429
(100 %)
9 diff
(98.0 %id)
H47219 liver and spleen .b 10674 to 11056 1 to 394   fully sequenced,   394/394
(100 %)
15 diff
(96.2 %id)
H67572 liver and spleen .b 10674 to 11105 1 to 440       440/443
(99 %)
13 diff
(97.1 %id)
BQ189211 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 10683 to 11339 1 to 660   fully sequenced,   660/660
(100 %)
6 diff
(99.1 %id)
TI_151765570   .b 10683 to 11311 92 to 721       630/1107
(56 %)
21 diff
(98.2 %id)
TI_151731476   .b 10683 to 11342 723 to 63       661/1063
(62 %)
0 diff
(100 %id)
BE697474 colon .b 10699 to 10821 19 to 139       121/139
(87 %)
6 diff
(95.7 %id)
CA449743 Chondrosarcoma, Left Pelvis .b 10701 to 11334 632 to 1       632/632
(100 %)
2 diff
(99.7 %id)
BQ008150 Chondrosarcoma, Left Pelvis .b 10702 to 11321 638 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 620/620
(100 %)
0 diff
(100 %id)
DB728123 testis .b 10726 to 11344 112 to 730     Submitted on the opposite strand 619/730
(84 %)
6 diff
(99.2 %id)
AA526904 breast .b 10758 to 11320 555 to 1       555/555
(100 %)
30 diff
(94.6 %id)
AW665187 pooled .b 10775 to 11324 551 to 1       551/551
(100 %)
6 diff
(99.0 %id)
BF057297 pooled germ cell tumors .b 10775 to 11321 547 to 1       547/547
(100 %)
0 diff
(100 %id)
DB348086 trachea .b 10779 to 11321 543 to 1       543/543
(100 %)
0 diff
(100 %id)
BU623435 cell lines, Enchondroma .b 10782 to 11321 558 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 540/548
(98 %)
0 diff
(100 %id)
DB324261   .b 10784 to 11346 562 to 1       562/562
(100 %)
1 diff
(99.9 %id)
BE048355 Kidney .b 10785 to 11319 539 to 5       535/539
(99 %)
0 diff
(100 %id)
AI961096 pooled germ cell tumors .b 10786 to 11321 536 to 1       536/536
(100 %)
6 diff
(98.9 %id)
DB315370 brain .b 10789 to 11346 553 to 1       553/553
(100 %)
2 diff
(99.7 %id)
BQ446445 Knee, Osteoarthritic Cartilage .b 10790 to 11321 550 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 532/541
(98 %)
0 diff
(100 %id)
AI916447 carcinoid, lung .b 10793 to 11324 532 to 1       532/532
(100 %)
0 diff
(100 %id)
AA127609 lung, lung carcinoma .b 10827 to 11063 1 to 239   fully sequenced,   239/239
(100 %)
4 diff
(98.4 %id)
AA136437 lung, lung carcinoma .b 10827 to 11264 1 to 438       438/438
(100 %)
5 diff
(98.9 %id)
AA136317 lung, lung carcinoma .b 10827 to 10966 1 to 140       140/145
(96 %)
3 diff
(98.0 %id)
BF449037 Prostate .b 10827 to 11321 496 to 1       496/496
(100 %)
1 diff
(99.8 %id)
AI476506 pooled .b 10856 to 11324 470 to 1       470/470
(100 %)
1 diff
(99.8 %id)
AI337394 colon, colon tumor, RER+ .b 10860 to 11317 457 to 1       457/457
(100 %)
1 diff
(99.8 %id)
BF939123 carcinoid, lung .b 10860 to 11324 465 to 1       465/465
(100 %)
1 diff
(99.8 %id)
AI221814 pooled .b 10864 to 11323 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AA831752 germinal center B cell .b 10867 to 11331 466 to 1       466/466
(100 %)
2 diff
(99.6 %id)
BE048416 Kidney .b 10872 to 11320 449 to 1       449/449
(100 %)
1 diff
(99.8 %id)
CB995832 placenta, pre-eclamptic placenta .b 10876 to 11344 27 to 490   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 464/490
(94 %)
6 diff
(98.8 %id)
AW471331 adenocarcinoma, Pancreas .b 10877 to 11346 469 to 1       469/469
(100 %)
2 diff
(99.6 %id)
AI669936 Prostate .b 10879 to 11321 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AA495819 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 10890 to 11321 432 to 1       432/432
(100 %)
3 diff
(99.4 %id)
AW189116 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 10896 to 11321 426 to 1       426/426
(100 %)
0 diff
(100 %id)
BE670370 carcinoid, lung .b 10903 to 11324 422 to 1       422/422
(100 %)
2 diff
(99.6 %id)
AW003272 pooled germ cell tumors .b 10917 to 11317 400 to 1       400/400
(100 %)
1 diff
(99.8 %id)
BE466229 pooled germ cell tumors .b 10917 to 11317 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
CD105446 brain, Pituitary .b 10920 to 11321 1 to 402   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 402/402
(100 %)
0 diff
(100 %id)
AW236396 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 10925 to 11323 399 to 1       399/399
(100 %)
0 diff
(100 %id)
BF061359 pooled .b 10925 to 11346 428 to 12   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 417/417
(100 %)
2 diff
(99.6 %id)
AA047770 heart .b 10926 to 11322 1 to 398   fully sequenced,   398/398
(100 %)
7 diff
(98.3 %id)
BX112422 heart .b 10927 to 11321 1 to 395   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 395/395
(100 %)
1 diff
(99.8 %id)
AI336093 lung .b 10928 to 11345 418 to 1       418/418
(100 %)
0 diff
(100 %id)
BQ369736 placenta_normal .b 10929 to 11250 346 to 25       322/346
(93 %)
21 diff
(94.0 %id)
AA192806 muscle, skeletal muscle .b 10941 to 11321 383 to 1       383/383
(100 %)
5 diff
(98.7 %id)
FN173573 breast carcinoma .b 10950 to 11043 95 to 1     Submitted on the opposite strand 95/95
(100 %)
1 diff
(99.0 %id)
BX485692   .b 10954 to 11320 387 to 20   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 368/373
(98 %)
2 diff
(99.5 %id)
F29926 pectoral muscle (after mastectomy) .b 10957 to 11220 1 to 264       264/264
(100 %)
0 diff
(100 %id)
AI034415 parathyroid gland, parathyroid tumor .b 10958 to 11341 390 to 6       385/390
(98 %)
0 diff
(100 %id)
AI038098 parathyroid gland, parathyroid tumor .b 10958 to 11341 390 to 6       385/390
(98 %)
0 diff
(100 %id)
W72597 heart .b 10960 to 11289 330 to 1   fully sequenced,   330/330
(100 %)
2 diff
(99.4 %id)
W76591 heart .b 10962 to 11317 59 to 416   fully sequenced,   358/416
(86 %)
6 diff
(98.6 %id)
AI963021 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 10967 to 11347 376 to 1   tiling clone,   376/376
(100 %)
6 diff
(98.5 %id)
AW166342 cervix .b 10969 to 11344 371 to 1       371/371
(100 %)
7 diff
(98.2 %id)
AI094559 pooled .b 10973 to 11321 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AI910539 pooled .b 10974 to 11340 368 to 1       368/368
(100 %)
1 diff
(99.8 %id)
BM664153 eye, Retina Foveal and Macular .b 10979 to 11321 361 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 343/343
(100 %)
0 diff
(100 %id)
AI758474 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 10980 to 11323 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
AA300030 uterus .b 10987 to 11321 335 to 1       335/335
(100 %)
0 diff
(100 %id)
AW449799   .b 10989 to 11346 375 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 358/358
(100 %)
1 diff
(99.8 %id)
AI678294 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 10997 to 11324 328 to 1       328/328
(100 %)
2 diff
(99.4 %id)
CK299379 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 11007 to 11339 333 to 1   fully sequenced,   333/333
(100 %)
2 diff
(99.4 %id)
BX642275   .b 11011 to 11331 323 to 1     Submitted on the opposite strand 323/323
(100 %)
3 diff
(99.1 %id)
AI769006 pooled .b 11018 to 11341 330 to 6       325/330
(98 %)
0 diff
(100 %id)
H47120 liver and spleen .b 11026 to 11307 286 to 1   fully sequenced,   286/286
(100 %)
3 diff
(99.0 %id)
AA127512 lung, lung carcinoma .b 11033 to 11322 292 to 1   fully sequenced,   292/292
(100 %)
0 diff
(100 %id)
CA453465 mixed (pool of 40 RNAs) .b 11040 to 11337 1 to 301       301/337
(89 %)
8 diff
(97.7 %id)
C06386   .b 11056 to 11345 291 to 7       285/291
(97 %)
0 diff
(100 %id)
FN057089 breast carcinoma .b 11059 to 11149 1 to 92       92/93
(98 %)
3 diff
(96.8 %id)
FN060767 breast carcinoma .b 11059 to 11149 1 to 93       93/94
(98 %)
3 diff
(96.9 %id)
BF082035 amnion_normal .b 11067 to 11280 1 to 213       213/218
(97 %)
13 diff
(94.1 %id)
BF082033 amnion_normal .b 11079 to 11280 22 to 221       200/226
(88 %)
6 diff
(97.4 %id)
BE698660 uterus_tumor .b 11084 to 11269 186 to 2       185/186
(99 %)
0 diff
(100 %id)
BF379366 uterus_tumor .b 11084 to 11280 239 to 40       200/239
(83 %)
0 diff
(100 %id)
AI926885 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 11089 to 11321 234 to 1       234/234
(100 %)
1 diff
(99.6 %id)
AA741160 germinal center B cell .b 11107 to 11340 244 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 234/234
(100 %)
1 diff
(99.6 %id)
AA278289 germinal center B cell .b 11110 to 11321 212 to 1       212/212
(100 %)
0 diff
(100 %id)
CA312187 Human Lung Epithelial cells, lung .b 11115 to 11321 226 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 208/210
(99 %)
2 diff
(99.1 %id)
BF840211 head_neck .b 11116 to 11285 1 to 169       169/169
(100 %)
3 diff
(98.3 %id)
AA057773 heart .b 11155 to 11317 164 to 1   fully sequenced,   164/164
(100 %)
0 diff
(100 %id)
FN108190 breast carcinoma .b 11157 to 11263 1 to 108       108/110
(98 %)
4 diff
(96.4 %id)
FN158599 breast carcinoma .b 11215 to 11316 1 to 100       100/100
(100 %)
2 diff
(98.0 %id)
AI625113 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 11217 to 11339 1 to 124     Submitted on the opposite strand 124/131
(94 %)
6 diff
(95.5 %id)
DR978653 brain .b 11240 to 11320 1 to 80     Submitted on the opposite strand 80/91
(87 %)
4 diff
(95.7 %id)
BC034987 testis .c 1 to 4542 5 to 4544 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 4540/4540
(100 %)
4 diff
(100.0 %id)
BI460455 testis .c 3 to 770 8 to 776   available from MGC,   769/776
(99 %)
22 diff
(97.2 %id)
DB459717 testis .c 5 to 454 1 to 451       451/451
(100 %)
3 diff
(99.4 %id)
BF763222 colon_est .c 607 to 990 1 to 384   tiling clone,   384/384
(100 %)
2 diff
(99.5 %id)
DA773651 brain .c 2013 to 2587 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AA079640 Pancreas .d 1 to 209 1 to 207   tiling clone,   207/218
(94 %)
3 diff
(98.7 %id)
AA026763 heart .d 726 to 924 1 to 199   tiling clone,   199/199
(100 %)
2 diff
(99.0 %id)
CB053281 leiomyosarcoma, soft tissue .d 813 to 1366 20 to 573   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 554/573
(96 %)
7 diff
(98.8 %id)
CB053280 leiomyosarcoma, soft tissue .d 855 to 1367 536 to 24   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
AI273672 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 937 to 1367 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AA076672 Pancreas .d 940 to 1371 431 to 1   tiling clone,   431/431
(100 %)
2 diff
(99.6 %id)
AA026764 heart .d 1021 to 1194 174 to 1       174/182
(95 %)
0 diff
(100 %id)
DA917032 small intestine .e-u 1 to 564 2 to 565 exact tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
AW899958 nervous_normal .e-u 98 to 342 1 to 243       243/244
(99 %)
8 diff
(96.8 %id)
AW892911 nervous_normal .e-u 246 to 855 9 to 618   tiling clone,   610/626
(97 %)
4 diff
(99.4 %id)
BG571387 placenta .f-u 1 to 728 1 to 725 L44C F45S M46* tiling clone,   725/726
(99 %)
10 diff
(98.7 %id)
BF741516 bocio_tumor Gene ZNF652, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB358418 whole embryo, mainly head Gene ZNF652, variant not shown              
DA571549 whole embryo, mainly head Gene ZNF652, variant not shown       capped      
AW977348   Gene ZNF652, variant not shown         Submitted on the opposite strand    
AW801841 uterus Gene ZNF652, variant not shown              
BX108138 pooled Gene ZNF652, variant not shown       AAA This clone was ignored    
AA872990 germinal center B cell Gene ZNF652, variant not shown       AAA This clone was ignored    
AI283456 pooled Gene ZNF652, variant not shown         This clone was ignored    
BG564435 Liver Gene ZNF652, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
DB070414 testis Gene ZNF652, variant not shown       capped This clone was ignored    
DB340122 testis Gene ZNF652, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC